HI
Humankind Investments Portfolio holdings
AUM
$410M
1-Year Return
11.36%
This Quarter Return
+6.86%
1 Year Return
+11.36%
3 Year Return
+48.94%
5 Year Return
–
10 Year Return
–
AUM
$410M
AUM Growth
+$25.1M
(+6.5%)
Cap. Flow
+$1.44M
Cap. Flow
% of AUM
0.35%
Top 10 Holdings %
Top 10 Hldgs %
64.33%
Holding
164
New
15
Increased
61
Reduced
60
Closed
17
Top Buys
| 1 |
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
$5M |
| 2 |
Archer Daniels Midland
ADM
|
$2.5M |
| 3 |
Johnson & Johnson
JNJ
|
$2.27M |
| 4 |
Bunge Global
BG
|
$1.64M |
| 5 |
GE HealthCare
GEHC
|
$860K |
Top Sells
| 1 |
Procter & Gamble
PG
|
$3.43M |
| 2 |
iShares TIPS Bond ETF
TIP
|
$2.83M |
| 3 |
The Mosaic Company
MOS
|
$1.98M |
| 4 |
Walmart
WMT
|
$1.26M |
| 5 |
Cigna
CI
|
$1.02M |
Sector Composition
| 1 | Healthcare | 13.4% |
| 2 | Technology | 12.59% |
| 3 | Consumer Staples | 4.8% |
| 4 | Communication Services | 2.86% |
| 5 | Materials | 1.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Deere & Co
DE
$128B
| $2.38M | 0.58% |
4,687
-1,486
| -24% | -$756K |
|
27
Abbott
ABT
$231B
| $2.29M | 0.56% |
16,808
+4,126
| +33% | +$561K |
|
28
Merck
MRK
$210B
| $2.19M | 0.53% |
27,671
-4,233
| -13% | -$335K |
|
29
Becton Dickinson
BDX
$54.8B
| $2.13M | 0.52% |
12,389
+4,337
| +54% | +$747K |
|
|
30
GE HealthCare
GEHC
$33.8B
| $2.07M | 0.51% |
28,009
+11,609
| +71% | +$860K |
|
|
31
The Mosaic Company
MOS
$10.4B
| $1.96M | 0.48% |
53,757
-54,357
| -50% | -$1.98M |
|
32
Stryker
SYK
$151B
| $1.94M | 0.47% |
4,901
+377
| +8% | +$149K |
|
33
Thermo Fisher Scientific
TMO
$185B
| $1.76M | 0.43% |
4,349
+1,772
| +69% | +$718K |
|
34
Corteva
CTVA
$49.3B
| $1.68M | 0.41% |
22,557
-11,858
| -34% | -$884K |
|
35
Amgen
AMGN
$151B
| $1.65M | 0.4% |
5,905
+253
| +4% | +$70.6K |
|
36
CVS Health
CVS
$93.5B
| $1.57M | 0.38% |
22,753
+11,126
| +96% | +$767K |
|
37
Gilead Sciences
GILD
$140B
| $1.57M | 0.38% |
14,150
+4,080
| +41% | +$452K |
|
38
Labcorp
LH
$22.9B
| $1.56M | 0.38% |
5,956
+147
| +3% | +$38.6K |
|
39
Bristol-Myers Squibb
BMY
$95B
| $1.51M | 0.37% |
32,606
+6,632
| +26% | +$307K |
|
40
Baxter International
BAX
$12.1B
| $1.47M | 0.36% |
48,708
+10,104
| +26% | +$306K |
|
41
UnitedHealth
UNH
$281B
| $1.37M | 0.33% |
4,399
+1,134
| +35% | +$354K |
|
42
Boston Scientific
BSX
$159B
| $1.33M | 0.32% |
12,360
+1,571
| +15% | +$169K |
|
43
Verizon
VZ
$186B
| $1.32M | 0.32% |
30,475
-1,451
| -5% | -$62.8K |
|
44
Amazon
AMZN
$2.51T
| $1.31M | 0.32% |
5,961
+1,641
| +38% | +$360K |
|
45
AT&T
T
$212B
| $1.29M | 0.31% |
44,554
-2,643
| -6% | -$76.5K |
|
46
Dell
DELL
$85.7B
| $1.23M | 0.3% |
10,025
-2,491
| -20% | -$305K |
|
47
Colgate-Palmolive
CL
$67.6B
| $1.17M | 0.29% |
12,888
-11,111
| -46% | -$1.01M |
|
48
Quest Diagnostics
DGX
$20.1B
| $1.12M | 0.27% |
6,219
+571
| +10% | +$103K |
|
49
Vertex Pharmaceuticals
VRTX
$102B
| $1.11M | 0.27% |
2,489
+494
| +25% | +$220K |
|
50
Comcast
CMCSA
$125B
| $1.1M | 0.27% |
30,707
+1,558
| +5% | +$55.6K |
|